XML 23 R14.htm IDEA: XBRL DOCUMENT v3.24.3
Warrants
9 Months Ended
Sep. 30, 2024
Warrants  
Warrants

6. Warrants

As of September 30, 2024, the number of shares of common stock issuable upon the exercise of outstanding warrants, consisted of the following:

September 30, 2024

Number of Common Shares

Description

    

Issuable

    

Exercise Price

    

Expiration Date

January 23 2017 Warrants

5,450

$

0.10

Upon M&A Event

2017 Warrants

250,227

$

2.82

November 2024

2019 Warrants

690,813

$

19.50

February 2026

March 2020 Pre-funded Warrants

824,718

$

0.01

No Expiry

March 2020 Coverage Warrants

2,594,503

$

21.10

Jan - March 2027

September 2021 Pre-funded Warrants

591,603

$

0.01

No Expiry

January 2023 Common Stock Warrants

50,830

$

6.78

February 2025

April 2024 Pre-funded Warrants

1,523,404

$

0.001

No Expiry

6,531,548

2017 Warrants

The 2017 Warrants contain full ratchet anti-dilution protection provisions. The Company will recognize on a prospective basis the value of the effect of the down round feature in the warrant when it is triggered (i.e., when the exercise price is adjusted downward). This value is measured as the difference between (1) the financial instrument’s fair value (without the down round feature) using the pre-trigger exercise price and (2) the financial instrument’s fair value (with the down round feature) using the reduced exercise price. The value of the effect of the down round feature will be treated as a dividend and a reduction to income available to common stockholders in the basic EPS calculation. In connection with the April 2024 Private Placement, when the 2017 Warrants were repriced from $10.55 to $2.82, the Company recorded a dividend of $234 during the nine months ended September 30, 2024.

2019 Warrants

During the three months ended March 31, 2023, the Company redeemed 10,000 of the 2019 Warrants at a purchase price of $2.90 per share.

January 2023 Common Stock Warrants

In January 2023, pursuant to the Merger, the warrants held by the Flame Warrant Holders became exercisable for 6,530 shares of Leap’s common stock (the “January 2023 Common Stock Warrants”). The January 2023 Common Stock Warrants have an exercise price of $6.78 per share and expire in February 2025. The January 2023 Common Stock Warrants qualify for equity classification.

January 2023 Series X Preferred Stock Warrants

In January 2023, pursuant to the Merger, the warrants held by the Flame Warrant Holders also became exercisable for 443 shares of Series X Preferred Stock (the “January 2023 Series X Preferred Stock Warrants”). Following Stockholder Approval, each share of Series X Preferred Stock converted into 100 shares of common stock during the three months ended June 30, 2023. The January 2023 Series X Preferred Stock Warrants have an exercise price of $6.78 per share and expire in February 2025.

The Company initially recorded the January 2023 Series X Preferred Stock Warrants as a liability on its condensed consolidated balance sheet as of the Effective Date and subsequently remeasured the warrant liability to fair value at each reporting date and on the date Stockholder Approval was obtained to convert shares of Series X Preferred Stock into shares of common stock. Changes in the fair value of the warrant liability were recognized as gains (losses) in the Company’s consolidated statement of operations. During the nine months ended September, 2023, the Company recorded a gain of $12 in its condensed consolidated statement of operations.

During the three months ended June 30, 2023, upon obtaining Stockholder Approval, the January 2023 Series X Preferred Stock Warrants were converted into common stock warrants and reclassified from liability to equity.